DrugPatentWatch Database Preview
Details for Patent: 8,354,409
Email this page to a colleague
See Plans and PricingWhich drugs does patent 8,354,409 protect, and when does it expire?
Patent 8,354,409 protects COMBIGAN and is included in one NDA.
This patent has twenty-five patent family members in nineteen countries.
Summary for Patent: 8,354,409
| Title: | Combination of brimonidine and timolol for topical ophthalmic use |
| Abstract: | Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans. |
| Inventor(s): | Chang; Chin-Ming (Tustin, CA), Beck; Gary J. (Fullerton, CA), Pratt; Cynthia C. (Mission Viejo, CA), Batoosingh; Amy L. (Mission Viejo, CA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 13/308,507 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,354,409 |
|
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 8,354,409
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | COMBIGAN | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021398-001 | Oct 30, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Y | REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE OR GLAUCOMA | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,354,409
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003228480 | Start Trial | |||
| Brazil | 0302584 | Start Trial | |||
| Canada | 2440764 | Start Trial | |||
| China | 100558364 | Start Trial | |||
| China | 101664414 | Start Trial | |||
| China | 1516588 | Start Trial | |||
| Cyprus | 1114048 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
